Aequus Pharmaceuticals

Aequus Pharmaceuticals Inc. is a specialty pharmaceutical company based in Vancouver, Canada, focused on the development and commercialization of innovative drug delivery methods in various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets several products, such as Vistita, which reduces intraocular pressure in patients with glaucoma, and Tacrolimus IR, an immunosuppressant used in organ transplantation. Additionally, Aequus offers Evolve dry eye products that address symptoms like discomfort and dryness, as well as preservative-free ophthalmic solutions. The company's development pipeline includes extended-release oral tablets for epilepsy and cannabinoid-based therapeutics for neurological disorders. Aequus has established collaboration agreements with several partners to enhance its product offerings and market reach. Founded in 2013, Aequus Pharmaceuticals aims to improve patient compliance and therapeutic outcomes through its innovative approaches.